Onyx Healthcare Inc. (TPEX:6569)
105.50
-3.50 (-3.21%)
At close: Jul 8, 2026
Onyx Healthcare Market Cap
Onyx Healthcare has a market cap or net worth of 4.16 billion as of July 9, 2026. Its market cap has decreased by -12.22% in one year.
Market Cap
4.16B
Enterprise Value
4.23B
Revenue
1.38B
Ranking
n/a
PE Ratio
28.74
Stock Price
105.50
Market Cap Chart
Since January 15, 2016, Onyx Healthcare's market cap has increased from 1.94B to 4.16B, an increase of 114.88%. That is a compound annual growth rate of 7.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 4.12B | -3.65% |
| Dec 31, 2025 | 4.28B | -27.59% |
| Dec 31, 2024 | 5.91B | 2.52% |
| Dec 29, 2023 | 5.76B | 77.16% |
| Dec 30, 2022 | 3.25B | 2.87% |
| Dec 30, 2021 | 3.16B | -11.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 529.73B |
| Caliway Biopharmaceuticals | 162.64B |
| Heron Neutron Medical | 69.62B |
| Pell Bio-Med Technology | 59.93B |
| Bionime | 4.41B |
| Easywell Biomedicals | 4.15B |
| Orient EuroPharma | 4.12B |
| Senhwa Biosciences | 4.01B |